Showing results (171-180 of 1,997) with videos related to
Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|December 17, 2008
Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk?Fabrizio Montecucco, Francois MachEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Type I interferon as a target of treatment in SLEP Y Lee, W H ReevesEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20)Robert EisenbergEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
NF-kappaB and rheumatic diseasesTakashi OkamotoEndocrine, Metabolic & Immune Disorders Drug Targets|January 12, 2007
Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositisHideto Kameda, Tsutomu TakeuchiEndocrine, Metabolic & Immune Disorders Drug Targets|March 31, 2010
WNT4 signaling in female gonadal developmentMiriam Pellegrino, Raffaella Maiorino, Sergio SchonauerEndocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
The cannabinoid 2 receptor as a potential therapeutic target for sepsisKevin Richard Kasten, Johannes Tschöp, Matthias Hans Tschöp, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
Metabolic acidosis in sepsisAlexandre Toledo Maciel, Danilo Teixeira Noritomi, Marcelo ParkEndocrine, Metabolic & Immune Disorders Drug Targets|June 1, 2010
Neurohypophyseal dysfunction during septic shockAlexandre Giusti-Paiva, Michael Brian SantiagoEndocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2007
Chemokines as drug targets in type 1 diabetesUrs ChristenPageof 200